| |
Total
|
Medication
|
PTCA
|
CABG
|
p
|
---|
| |
214
|
70
|
71
|
73
| |
Gender
|
Male
|
175
|
52
|
57
|
66
| |
|
Female
|
39
|
18
|
14
|
7
|
0.041
|
Age
|
Mean
|
64.09
|
66.00
|
62.03
|
64.26
|
0.078
|
Education level
|
Mean
|
2.04
|
1. 97a
|
2.51b
|
1.64a
|
<0.001
|
Angiogram scores
|
LAD artery disease
|
2.18
|
1.56a
|
2.31b
|
2.64b
|
<0.001
|
|
Circumflex artery disease
|
1.67
|
1.30a
|
1.39a
|
2.30b
|
<0.001
|
|
RCA disease
|
1.98
|
1.80
|
1.85
|
2.27
|
0.015
|
|
Number of disease vessels
|
2.51
|
2.39a
|
2.37a
|
2.77b
|
0.002
|
|
Ventricular Function score
|
0.63
|
0.56a
|
0.39a
|
0.93b
|
<0.001
|
Symptom frequency
|
Angina
|
2.03
|
1.80a
|
2.18b
|
2.11b
|
0.005
|
|
Dyspnoea
|
2.22
|
2.19
|
2.37
|
2.11
|
0.212
|
|
Non-cardiac
|
1.43
|
1.38
|
1.46
|
1.46
|
0.196
|
Functional limitations
|
Angina associated
|
1.80
|
1.29a
|
1.93b
|
2.15b
|
<0.001
|
|
Dyspnoea associated
|
1.56
|
1.21
|
1.67
|
1.79
|
0.013
|
Activities of daily living
|
Social Behaviour
|
4.43
|
3.96a
|
3.97a
|
5.32b
|
0.005
|
|
Emotional Stability
|
1.30
|
1.43
|
1.48
|
1.00
|
0.112
|
|
Mobility Range
|
1.91
|
1.00a
|
1.15a
|
3.52b
|
<0.001
|
|
Somatic Autonomy
|
0.84
|
0.94
|
0.58
|
0.99
|
0.200
|
|
Mobility Control
|
4.00
|
3.81
|
3.63
|
4.53
|
0.143
|
|
Psychological Autonomy & Communication
|
1.71
|
1.89
|
1.75
|
1.51
|
0.613
|
- Gender analyses conducted with Chi-sq test, remainder with ANOVAs.
- Significant treatment group differences revealed within the ANOVAs are indicated with different superscript letters.